90 related articles for article (PubMed ID: 2881562)
1. [Recent advances in biochemical studies of dementia in the elderly].
Nishimura T; Yamashita T; Tada K; Cacabelos R; Niikawa H; Suzuki H
No To Shinkei; 1987 Jan; 39(1):9-16. PubMed ID: 2881562
[No Abstract] [Full Text] [Related]
2. [Internal neurology--a. Trends in the study of dementia and cerebrovascular disorders].
Fukuyama H; Kameyama M
Nihon Rinsho; 1987 Sep; 45(9):2125-32. PubMed ID: 2892955
[No Abstract] [Full Text] [Related]
3. [Neurotransmitter abnormalities in the dementia of Alzheimer type].
Sasaki H; Arai H
Rinsho Shinkeigaku; 1986 Dec; 26(12):1290-3. PubMed ID: 2881639
[No Abstract] [Full Text] [Related]
4. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
[TBL] [Abstract][Full Text] [Related]
5. [Neurotransmitter anomalies in Alzheimer's disease].
Berger B
Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
[TBL] [Abstract][Full Text] [Related]
6. [Biochemistry of biogenic amines--recent advances].
Nagatsu T
Yakubutsu Seishin Kodo; 1983 May; 3(1):1-9. PubMed ID: 6141683
[No Abstract] [Full Text] [Related]
7. [Cerebral metabolic activator (author's transl)].
Ishihara N; Gotoh F
No To Shinkei; 1979 Aug; 31(8):739-49. PubMed ID: 40583
[No Abstract] [Full Text] [Related]
8. An update on the neurochemistry of Alzheimer disease.
Davies P
Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
[No Abstract] [Full Text] [Related]
9. Recent advances in the neurochemistry of Alzheimer's disease.
Davies P; Wolozin BL
J Clin Psychiatry; 1987 May; 48 Suppl():23-30. PubMed ID: 2883177
[TBL] [Abstract][Full Text] [Related]
10. [The metabolism of ethanol. II. Action of ethanol on biological amines].
Gajdos A
Ann Biol Clin (Paris); 1974; 32(6):479-85. PubMed ID: 4157113
[No Abstract] [Full Text] [Related]
11. [Cerebral ischemia and changes in the brain monoamines].
Kogure K
No To Shinkei; 1983 Jan; 35(1):33-9. PubMed ID: 6197078
[No Abstract] [Full Text] [Related]
12. 5-HT receptor regulation of neurotransmitter release.
Fink KB; Göthert M
Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
[TBL] [Abstract][Full Text] [Related]
13. Functional pharmacology in human brain.
Raiteri M
Pharmacol Rev; 2006 Jun; 58(2):162-93. PubMed ID: 16714485
[TBL] [Abstract][Full Text] [Related]
14. The brain cholinergic system in ageing mammals.
Pepeu G; Casamenti F; Pepeu IM; Scali C
J Reprod Fertil Suppl; 1993; 46():155-62. PubMed ID: 8315616
[TBL] [Abstract][Full Text] [Related]
15. [Tauopathy and Alzheimer disease: a full degenerating process].
Buée L; Delacourte A
Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
[TBL] [Abstract][Full Text] [Related]
16. Biochemical aspects of brain ischemia.
Kometiani PA
Neuropatol Pol; 1980; 18(4):507-19. PubMed ID: 6166894
[No Abstract] [Full Text] [Related]
17. Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain.
Van Dam D; Marescau B; Cremers T; Mulder J; Engelborghs S; De Deyn PP
Amino Acids; 2005 Jun; 28(4):377-87. PubMed ID: 15889219
[TBL] [Abstract][Full Text] [Related]
18. [Tau protein abnormality and dementia: the mechanisms of neurodegeneration].
Tanaka T; Takeda M
No To Shinkei; 2002 Sep; 54(9):777-87. PubMed ID: 12428364
[No Abstract] [Full Text] [Related]
19. [Alterations in cholinergic and adrenergic receptors in senile dementia of the Alzheimer's-type].
Shimohama S; Kameyama M
Rinsho Shinkeigaku; 1986 Dec; 26(12):1294-7. PubMed ID: 3030597
[No Abstract] [Full Text] [Related]
20. [Sympathetic mediator theory of the pathogenesis of progressive muscular dystrophies (a review)].
Badalian LO; Temin PA; Dzhabarov BD; Il'in IL; Kovaleva MIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1722-6. PubMed ID: 6119861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
